Maren I. Blonk

Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy

Maren I. Blonk, Angela Colbers, Carmen Hidalgo-Tenorio et al. · Clinical Infectious Diseases · 2015 · 63 citations

Medicine, Pharmacokinetics, Pharmacology +17

Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography–tandem mass spectrometry

Maren I. Blonk, Bart C.H. van der Nagel, Liesbeth S. Smit et al. · Journal of Chromatography B · 2010 · 46 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Effect of Ginkgo Biloba on the Pharmacokinetics of Raltegravir in Healthy Volunteers

Maren I. Blonk, Angela Colbers, Anne Poirters et al. · Antimicrobial Agents and Chemotherapy · 2012 · 36 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Lack of a Clinically Significant Drug–Drug Interaction in Healthy Volunteers Between the Hepatitis C Virus Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir

Clara T. M. M. de Kanter, Maren I. Blonk, Angela Colbers et al. · Clinical Infectious Diseases · 2012 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

CYP2D6*4, CYP3A5*3 and ABCB1 3435T polymorphisms and drug-related falls in elderly people

Maren I. Blonk, Nathalie van der Velde, Patricia M. L. A. van den Bemt et al. · Pharmacy World & Science · 2009 · 14 citations

Medicine, Pharmacokinetics, Pharmacology +16